Translational Autoimmunity, Volume 2

Treatment of Autoimmune Diseases

Häftad, Engelska, 2022

2 179 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Translational Autoimmunity: Treatment of Autoimmune Diseases, Volume Two in the Translational Immunology series, focuses on advances in therapeutic modalities in autoimmune diseases. Efficacy and safety of not only the current biologic therapies, but also novel drug targets are discussed. Therapeutic targeting of B regulatory cells, T regulatory cells, as well as the immunomodulation effects of nanoparticles and organisms are also covered, along with our� understanding and future challenges of prognostic significance of treatments in autoimmune diseases.

Covers the clinical aspects and treatment of autoimmunite diseases
Meets the needs of basic scientists, clinicians and translational scientists and industry partners
Mentions each and every key concept after background is drawn
Supported by a systematic appraisal of the most recent evidence
Helps students at all academic levels, but is also applicable to scientists who work with autoimmunity

Produktinformation

Utgivningsdatum2022-01-10
Mått191 x 235 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
SerieTranslational Immunology
Antal sidor486
FörlagElsevier Science
ISBN9780128243909

Tillhör följande kategorier

Onkologi inom Medicin

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the founding President of the Universal Scientific Education and Research Network (USERN). Professor Rezaei has already been the Director of more than 55 research projects and has designed and participated in several international collaborative projects. Professor Rezaei is an editorial assistant or board member for more than 30 international journals. He has edited more than 35 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,000 scientific papers in the international journals.

1. Introduction on therapeutic opportunities for autoimmunity2. Innate lymphoid cells as therapeutic targets in autoimmune diseases3. B regulatory cells in patients with autoimmune diseases: pathogenic significance, therapeutic potential4. Regulatory T cells in autoimmunity and potential therapeutic targets5. Application of IL-6 antagonists in autoimmune disorders6. The search for monomer interaction-based alternative TNFα therapies7. Generation of thymic cells from pluripotent stem cells for basic research and cell therapy8. The NLRP3 inflammasome pathway in autoimmune diseases: a chronotherapeutic perspective?9. Plasmocytes infiltrating autoimmune organs and their putative targeting10. Biological aging and autoimmunity11. Efficacy and safety of biologic treatment in autoimmune diseases12. Nutritional implications for the pathophysiology and treatment of autoimmune disorders13. Dysbiosis and probiotic applications in autoimmune diseases14. Precision medicine in managing chronic conditions with an immunological component15. New advanced therapy medicinal products in treatment of autoimmune diseases16. Targeting of autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches17. Immunomodulatory effects of parasites on autoimmunity18. Prediction of autoimmune diseases: from bench to bedside